HAVANA TIMES, Dec 30 — Polyclinics in Sancti Spiritus province are testing the lung cancer vaccine CIMAVAX-EGF, which was created in Cuba and is the only one registered in the world for this type of malignancy.

The drug has been in use for about nine months in five clinics in the province as part of a national study that now includes more than two thousand patients, reports the Prensa Latina news agency.

Though not a cure for the condition, the therapeutic vaccine increases life expectancy, decreases or eliminates shortness of breath, improves appetites and increases body weight, makes pain controllable and has few side effects.


Leave a Reply

Your email address will not be published. Required fields are marked *